MariMed Inc. (MRMD)
OTCMKTS: MRMD · Delayed Price · USD
0.270
-0.007 (-2.35%)
Apr 19, 2024, 3:30 PM EDT - Market closed
Company Description
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally.
The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand.
It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand.
In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand.
The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
MariMed Inc.
| Country | MA |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 643 |
| CEO | Jon R. Levine |
Contact Details
Address: 10 Oceana Way, 2nd Floor Norwood, Massachusetts 02062 United States | |
| Phone | 781-277-0007 |
| Website | marimedinc.com |
Stock Details
| Ticker Symbol | MRMD |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001522767 |
| CUSIP Number | 56782V107 |
| ISIN Number | US56782V1070 |
| Employer ID | 27-4672745 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Jon R. Levine | Co-Founder, Chief Executive Officer, Interim Chief Financial Officer, President, Secretary, Treasurer and Director |
| Timothy Shaw | Chief Operating Officer |
| Jonathan W. Rider | Chief Information Officer |
| Steve Wayne West | Vice President of Investor Relations |
| Howard Schacter | Chief Communications Officer |
| Sara Gullickson | Vice President of Marketing |
| Ryan Crandall | Chief Revenue Officer |
| Charles Holt Finnie | Chief Strategy Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 7, 2024 | 10-K | Annual Report |
| Mar 6, 2024 | 8-K | Current Report |
| Nov 20, 2023 | 8-K | Current Report |
| Nov 9, 2023 | 10-Q | Quarterly Report |
| Nov 8, 2023 | 8-K | Current Report |
| Nov 3, 2023 | 8-K | Current Report |
| Aug 4, 2023 | 10-Q | Quarterly Report |
| Aug 2, 2023 | 8-K | Current Report |
| Jun 12, 2023 | 8-K | Current Report |
| May 9, 2023 | 10-Q | Quarterly Report |